Disparities in liver cancer occurrence in the United States by race/ethnicity and state.

Disparities in liver cancer occurrence in the United States by race/ethnicity and state.

Item
http://www.wikidata.org/entity/Q38741005
Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence.Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States.Norcantharidin alone or in combination with crizotinib induces autophagic cell death in hepatocellular carcinoma by repressing c-Met-mTOR signaling.Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum.Liver Cancer Disparities in New York City: A Neighborhood View of Risk and Harm Reduction Factors.MicroRNA-29c restores cisplatin sensitivity in liver cancer through direct inhibition of sirtuin 1 expression.Liver cancer mortality trends in South Africa: 1999-2015MicroRNA regulation of liver cancer stem cells
P2860

Disparities in liver cancer occurrence in the United States by race/ethnicity and state.

Item
http://www.wikidata.org/entity/Q38741005
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Disparities in liver cancer occurrence in the United States by race/ethnicity and state.
@en
type
label
Disparities in liver cancer occurrence in the United States by race/ethnicity and state.
@en
prefLabel
Disparities in liver cancer occurrence in the United States by race/ethnicity and state.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Disparities in liver cancer occurrence in the United States by race/ethnicity and state.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698